{
    "2018-08-03": [
        [
            {
                "time": "2018-07-26",
                "original_text": "Boston Scientificâ€™s Q2 2018 Adjusted EPS Exceed Guidance",
                "features": {
                    "keywords": [
                        "Q2",
                        "Adjusted EPS",
                        "Exceed",
                        "Guidance"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-27",
                "original_text": "Can Boston Scientific Maintain Its Strong Sales Momentum?",
                "features": {
                    "keywords": [
                        "Strong Sales",
                        "Momentum"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-07-28",
                "original_text": "What Analysts Recommend for Boston Scientific, Post-Q2 Results",
                "features": {
                    "keywords": [
                        "Analysts Recommend",
                        "Post-Q2 Results"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-07-29",
                "original_text": "Zacks.com featured highlights include: Biogen, Thermo Fisher, HCA, Gilead and QUALCOMM",
                "features": {
                    "keywords": [
                        "Zacks.com",
                        "Biogen",
                        "Thermo Fisher",
                        "HCA",
                        "Gilead",
                        "QUALCOMM"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "technology"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}